Skip to main content

Table 3 The age-standardized incidence and mortality rates along with the ASR -based mortality-to-incidence ratio due to leukemia among females of selected countries (n = 56)

From: Gender differences in leukemia outcomes based on health care expenditures using estimates from the GLOBOCAN 2020

Country

Incidence

Mortality

ASR-based MIR

ASIR

Cum.Risk

ASMR

Cum.Risk

2012

2020

δMIR

Argentina

4.9

0.89

2.9

0.7

0.71

0.59

0.12

Australia

8.4

1.77

2.6

1.02

0.42

0.31

0.11

Austria

6.2

1.25

2.6

0.92

0.28

0.42

-0.14

Belarus

6.7

1.02

3

0.76

0.62

0.45

0.17

Belgium

10.4

1.98

3.1

1.15

0.37

0.30

0.07

Brazil

4

0.81

2.7

0.68

0.66

0.67

-0.01

Bulgaria

4.6

0.68

2.3

0.69

0.56

0.50

0.06

Canada

7.6

1.58

2.6

0.92

0.31

0.34

-0.03

Chile

5.1

0.87

2.7

0.67

0.58

0.53

0.05

Colombia

5.4

0.94

3.5

0.76

0.63

0.65

-0.02

Costa Rica

5.6

0.91

3

0.72

0.62

0.53

0.09

Croatia

5

1.19

3.4

1.08

0.39

0.68

-0.29

Cuba

4.6

0.78

2.6

0.61

0.60

0.56

0.04

Cyprus

6.5

1.59

3.6

1.45

0.35

0.55

-0.20

Czechia

5.6

1.28

2.7

0.91

0.44

0.48

-0.04

Denmark

6.6

1.33

3.1

1.13

0.40

0.47

-0.07

Ecuador

5.9

1.04

4.3

0.89

0.71

0.73

-0.02

Egypt

5.1

0.87

3.9

0.87

0.75

0.76

-0.01

Estonia

6.8

1.25

2.9

0.94

0.46

0.43

0.03

Finland

5.4

1.03

2

0.68

0.31

0.37

-0.06

France

7

1.59

2.6

1.01

0.33

0.37

-0.04

Germany

6.7

1.36

2.7

1.04

0.21

0.40

-0.19

Iceland

4

0.81

1.7

0.63

0.26

0.42

-0.16

Ireland

7.4

1.46

2.5

0.91

0.25

0.34

-0.09

Italy

6.8

1.27

2.8

0.89

0.22

0.41

0.19

Jamaica

4.4

0.64

3.3

0.6

0.67

0.75

-0.08

Japan

5.4

0.78

1.7

0.51

0.25

0.31

-0.06

Kuwait

6.6

1.64

4.2

1.24

0.55

0.64

-0.09

Latvia

6.9

1.4

3.4

1.08

0.57

0.49

0.08

Lithuania

8.7

1.76

2.9

1.08

0.60

0.33

0.27

Luxembourg

3.1

1.23

1.8

0.88

0.35

0.58

-0.23

Malaysia

5.6

0.69

3.9

0.61

0.72

0.69

0.03

Malta

5

0.99

1.3

0.54

0.31

0.26

0.05

Mauritius

5.1

0.74

2.9

0.63

0.54

0.57

-0.03

Netherlands

6.3

1.16

2.5

0.97

0.30

0.39

-0.09

New Zealand

7.6

1.62

3.4

1.24

0.40

0.45

-0.05

Norway

7.2

1.46

2.4

0.8

0.30

0.33

-0.03

Philippines

5.1

0.86

3.7

0.71

0.63

0.72

-0.09

Poland

5.7

1.25

3.1

0.97

0.52

0.54

-0.02

Portugal

6.3

1.28

2.7

0.83

0.34

0.43

-0.09

Qatar

3.5

0.37

2.4

0.3

0.47

0.68

-0.21

Russian Federation

5.7

0.92

2.7

0.61

0.56

0.47

0.09

Serbia

6.6

1.1

3.3

0.81

0.64

0.50

0.14

Singapore

7.9

1.28

2.5

0.68

0.31

0.32

-0.01

Slovakia

6.5

1.5

4.4

1.26

0.50

0.68

-0.18

Slovenia

6

1.43

2.9

1.19

0.36

0.48

-0.12

South Africa

2.9

0.73

2.2

0.63

0.75

0.76

-0.01

Spain

5.6

1.07

2.2

0.77

0.25

0.39

-0.14

Sweden

6.2

1.16

2.4

0.92

0.30

0.39

-0.09

Switzerland

6

1.16

2.1

0.73

0.24

0.35

-0.11

Thailand

4.9

0.76

3

0.58

0.60

0.61

-0.01

Trinidad and Tobago

5.1

0.6

3.5

0.51

0.68

0.69

-0.01

Ukraine

4.9

0.66

2.5

0.4

0.55

0.51

0.04

United Kingdom

7

1.51

2.2

0.85

0.33

0.31

0.02

United States of America

9

1.87

2.5

0.88

0.54

0.28

0.26

Uruguay

5.1

1.07

2.7

0.84

0.66

0.53

0.13

  1. ASIR age-standardized incidence rate, Cum cumulative, ASMR age-standardized mortality rate, MIR mortality-to-incidence ratio